Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer

Neoplasia(2020)10.1016/j.neo.2019.11.001Source: DataRank Database

Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer is a research paper published in Neoplasia (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (43)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Avi Prajapati,Mansi Gulati,Shailendra K. Gautam ORCID,Sushil Kumar ORCID,Vipin Dalal

Live enrichment

PubMed:31923844 PMC:PMC6951489

NCI NIH HHS

Grant: U01 CA200466

NCI NIH HHS

Grant: R01 CA195586

NCI NIH HHS

Grant: U01 CA213862

National Institutes of Health

Grant: 3U01CA200466-02S1

Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms

National Institutes of Health

Grant: 5U01CA213862-04

Nanovaccine platforms to combat pancreatic cancer

National Institutes of Health

Grant: 5R01CA195586-05

Targeted Radiation Therapy for Pancreatic Cancer

National Institutes of Health

goldLicense: cc-by-nc-nd

publisherhttps://www.sciencedirect.com/science/article/pii/S1476558619302544/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1476558619302544?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1476558619302544?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/6951489

Europe_PMChttps://europepmc.org/articles/PMC6951489

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

AnimalsHumansMicePancreatic NeoplasmsPancreatitisDisease Models, AnimalInflammationAmylasesEndothelin-1Receptor, Endothelin AReceptor, Endothelin BGene Expression RegulationOncogenesProto-Oncogene Proteins p21(ras)CeruletideEndothelin-Converting Enzymes

Keywords

EndothelinPancreatitisPrecancerous lesionsPancreatic injuryAcinar-ductal MetaplasiaOncogenic K-rasPanin LesionsInflammationOriginal articleEndothelin-1Neoplasms. Tumors. Oncology. Including cancer and carcinogensOncogenesEndothelin-Converting EnzymesReceptor, Endothelin AReceptor, Endothelin BPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Disease Models, AnimalMiceGene Expression RegulationAmylasesAnimalsHumansRC254-282Ceruletide

Sustainable Development Goals

SDG 3: 3. Good healthSDG 12: 12. Responsible consumption

Additional file 1 of Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells

10.6084/m9.figshare.24784636.v1figshare

Additional file 1 of Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells

10.6084/m9.figshare.24784636figshare